🇺🇸 FDA
Pipeline program

Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)

220901

Approved mab completed

Quick answer

Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination) for Prothrombin Complex Factor Deficiency is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Prothrombin Complex Factor Deficiency
Phase
Approved
Modality
mab
Status
completed

Clinical trials